Pharmaceutical Care Management Association

Pharmacy middlemen sue to stop rebate transparency

BY: - August 20, 2021

An industry group representing powerful drug middlemen has gone to court to stop a federal rule intended to bring transparency to rebates middlemen get from manufacturers. The middlemen are arguing that the rule, initiated by the Trump administration, will increase drug costs. But the group’s critics say that secretive rebates are a primary driver of […]

Drug-pricing practice could be banned to help pay for infrastructure bill

BY: - July 29, 2021

Drug-pricing practice could be banned to help pay for infrastructure bill.

Big PBM decision undergoes its first test

BY: - July 9, 2021

The stakes appear to be pretty high. After a unanimous ruling in a related case in December, the U.S. Supreme Court has reopened a case regarding sweeping regulations of powerful middlemen known as pharmacy benefit managers — and 30 state attorneys general and many others are joining the fray. Pharmacy benefit managers, or PBMs, are […]

Chucking insurance

BY: - June 22, 2021

To a growing number of pharmacists, using insurance to pay for most generic drugs makes about as much sense as getting auto insurance to cover your oil changes. Problem is, if you try to buy generics without using your insurance card at the vast, vast majority of American pharmacies, you’re going to pay a “cash” […]

Antitrust concerns are increasing on Capitol Hill. Advocates say they should extend to drug pricing

BY: - June 1, 2021

Antitrust concerns are increasing on Capitol Hill. Advocates say they should extend to drug pricing.